Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Nodelman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Family Physician|June 21, 2024
RSVpreF (Abrysvo) and Nirsevimab-alip (Beyfortus) for the Prevention of Respiratory Syncytial Virus InfectionMatthew Nodelman, A Miles Scott
FP Essentials|May 8, 2026
Obesity Management: EvaluationA Miles Scott, Morgan A Rhodes, Mark Shaffer, et al.
FP Essentials|May 8, 2026
Obesity Management: Surgical InterventionsMark Shaffer, Matthew Nodelman, A Miles Scott, et al.
FP Essentials|May 8, 2026
Obesity Management: PharmacotherapyMorgan A Rhodes, A Miles Scott, Matthew Nodelman, et al.
FP Essentials|May 8, 2026
Obesity Management: Lifestyle InterventionsMatthew Nodelman, Mark Shaffer, Morgan A Rhodes, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Family Physician|June 21, 2024
RSVpreF (Abrysvo) and Nirsevimab-alip (Beyfortus) for the Prevention of Respiratory Syncytial Virus InfectionMatthew Nodelman, A Miles Scott
FP Essentials|May 8, 2026
Obesity Management: EvaluationA Miles Scott, Morgan A Rhodes, Mark Shaffer, et al.
FP Essentials|May 8, 2026
Obesity Management: Surgical InterventionsMark Shaffer, Matthew Nodelman, A Miles Scott, et al.
FP Essentials|May 8, 2026
Obesity Management: PharmacotherapyMorgan A Rhodes, A Miles Scott, Matthew Nodelman, et al.
FP Essentials|May 8, 2026
Obesity Management: Lifestyle InterventionsMatthew Nodelman, Mark Shaffer, Morgan A Rhodes, et al.
Pageof 1